SEARCH

SEARCH BY CITATION

References

  • 1
    Brett, S.J., Baxter, G., Cooper, H., Rowan, W., Regan, T., Tite, J., Rapson, N. (1996) Emergence of CD52, glycosylphosphatidyl-inositol-anchor-deficient lymphocytes in rheumatoid arthritis patients following Campath-1H treatment . International Immunology, 8, 325 334.
  • 2
    Hale, G., Xia, M.Q., Tighe, H.P., Dyer, M.J.S., Waldmann, H. (1990) The CAMPATH-1 antigen (CDw52). Tissue Antigens, 35, 118 127.
  • 3
    Hertenstein, B., Wagner, B., Bunjes, D., Duncker, C., Raghavachar, A., Arnold, R., Heimpel, H., Schrezenmeier, H. (1995) Emergence of CD52, phosphatidyl-inositolglycan-anchor-deficient T-lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphoma . Blood, 86, 1487 1492.
  • 4
    Hillmen, P., Lewis, S.M., Bessler, M., Luzzatto, L., Dacie, J.V. (1995) Natural history of paroxysmal nocturnal hemoglobinuria. New England Journal of Medicine, 333, 1253 1258.
  • 5
    Luzzatto, L. & Bessler, M. (1996) The dual pathogenesis of paroxysmal nocturnal haemoglobinuria. Current Opinions in Haematology, 3, 101 110.
  • 6
    Miyata, T., Takeda, J., Iida, Y., Yamada, N., Inoue, N., Takahashi, M., Maeda, K., Kitani, T., Kinoshita, T. (1993) The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science, 259, 1318 1320.
  • 7
    Osterborg, A., Dyer, M.J.S., Bunjes, D., Pangalis, G.A., Bastion, Y., Catovsky, D., Mellstedt, H. (1997) Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. Journal of Clinical Oncology, 15, 1567 1574.
  • 8
    Rosse, W.F. & Ware, R.E. (1995) The molecular basis of paroxysmal nocturnal hemoglobinuria. Blood, 86, 3277 3286.
  • 9
    Rotoli, B. & Luzzatto, L. (1989) Paroxysmal nocturnal haemoglobinuria. Seminars in Haematology, 26, 201 207.
  • 10
    Schrezenmeier, H., Hertenstein, B., Wagner, B., Raghavachar, A., Heimpel, H. (1995) A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by the high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins. Experimental Hematology, 23, 81 87.
  • 11
    Socie, G., Mary, J.Y., De Gramont, A., Rio, B., Leporrier, M., Rose, C., Heudier, P., Rochant, H., Cahn, J.Y., Gluckman, E. (1996) Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. Lancet, 348, 573 577.
  • 12
    Takeda, J., Miyata, T., Kawagoe, K., Iida, Y., Endo, Y., Fujita, T., Takahashi, M., Kitani, T., Kinoshita, T. (1993) Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria . Cell, 73, 703 711.
  • 13
    Taylor, V.C., Sims, M., Brett, S., Field, M.C. (1997) Antibody selection against CD52 produces a paroxysmal nocturnal haemoglobinuria phenotype in human lymphocytes by a novel mechanism. Biochemical Journal, 322, 919 925.
  • 14
    Yamada, N., Miyata, T., Maeda, K., Kitani, T., Takeda, J., Kinoshita, T. (1995) Somatic mutations of the PIG-A gene found in Japanese patients with paroxysmal nocutrnal hemoglobinuria. Blood, 85, 885 892.
  • 15
    Young, N.S. & Barrett, A.J. (1995) The treatment of acquired aplastic anemia. Blood, 85, 3367 3377.